Base de dados : HANSEN
Pesquisa : CLOFAZIMINA/QUIM [Descritor de assunto]
Referências encontradas : 4 [refinar]
Mostrando: 1 .. 4   no formato [Detalhado]

página 1 de 1

  1 / 4 HANSEN  
              next record last record
seleciona
para imprimir
Id:24469
Autor:World Health Organization.
Título:Leprosy.
Fonte:In: World Health Organization.Tropical diseases: progress in international research, 1987-1988. s.l, s.n, 1989. p.93-100ilus, graf.
Descritores:HANSENIASE/compl
HANSENIASE/diag
HANSENIASE/quimioter
HANSENIASE/imunol
HANSENIASE/fisiopatol
HANSENIASE/terap
MYCOBACTERIUM LEPRAE/imunol
MYCOBACTERIUM LEPRAE/fisiol
RIFAMPINA/sint quim
RIFAMPINA/imunol
DAPSONA/sint quim
 DAPSONA/imunol
 CLOFAZIMINA/quim
 CLOFAZIMINA/imunol
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1. aWC680, O14t


  2 / 4 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:20767
Autor:Salem, Isam Ismail; Steffan, Gerhard; Düzgünes, Nejat
Título:Efficacy of clofazimine - modified cyclodextrin against Mycobacterium avium complex in human macrophages
..-
Fonte:s.l; s.n; 2003. 10 p. graf.
Resumo:Clofazimine, a water insoluble substituted iminophenazine derivative with anti-mycobacterial and anti-inflammatory activity, is recommended by the WHO for the treatment of leprosy. It is also active against disseminated Mycobacterium avium complex (MAC) disease in HIV-infected patients. Recently, we achieved a 4000-fold increase of clofazimine water solubility using a novel modified clofazimine-cyclodextrin complex synthesized and patented by our group [Wasserlösliche, Iminiophenazinderivate enthaltende pharmazeutische Zusammensetzungen, deren Herstellung und Verwendung, German Patent, DE19814814C2]. In this paper we examine the activity of this complex against MAC in human macrophages, and evaluate its cytotoxicity. MAC-infected macrophages were treated for 24h with free or complexed clofazimine. The in vitro minimum inhibitory concentrations of both free and complexed clofazimine were 0.1 microg/ml. Free and complexed clofazimine inhibited the growth of MAC inside macrophages to a similar extent, while modified cyclodextrin alone had no observable effects on MAC or macrophages. Complexed clofazimine was not toxic to cells at concentrations effective against MAC. The TD(50) of the modified cyclodextrin in THP-1 cell line was 297 microg/ml. (AU).
Descritores:ANTIINFECCIOSOS/quim
ANTIINFECCIOSOS/farmacol
ANTIINFECCIOSOS/tox
CELULAS CULTIVADAS
CLOFAZIMINA/quim
CLOFAZIMINA/farmacol
CLOFAZIMINA/tox
MACROFAGOS/ef drogas
TESTES DE SENSIBILIDADE MICROBIANA
COMPLEXO MYCOBACTERIUM AVIUM/ef drogas
ESTEROIS/quim
ACIDO SUCCINICO
Limites:ESTUDO COMPARATIVO
HUMANO
ANIMAL
CAMUNDONGOS
Meio Eletrônico: - .
Localização:BR191.1; 09082/s


  3 / 4 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18954
Autor:Salem, Isam Ismail; Steffan, Gerhard; Düzgünes, Nejat
Título:Efficacy of clofazimine - modified cyclodextrin against Mycobacterium avium complex in human macrophages
..-
Fonte:s.l; s.n; 2003. 10 p. graf.
Resumo:Clofazimine, a water insoluble substituted iminophenazine derivative with anti-mycobacterial and anti-inflammatory activity, is recommended by the WHO for the treatment of leprosy. It is also active against disseminated Mycobacterium avium complex (MAC) disease in HIV-infected patients. Recently, we achieved a 4000-fold increase of clofazimine water solubility using a novel modified clofazimine-cyclodextrin complex synthesized and patented by our group [Wasserlösliche, Iminiophenazinderivate enthaltende pharmazeutische Zusammensetzungen, deren Herstellung und Verwendung, German Patent, DE19814814C2]. In this paper we examine the activity of this complex against MAC in human macrophages, and evaluate its cytotoxicity. MAC-infected macrophages were treated for 24h with free or complexed clofazimine. The in vitro minimum inhibitory concentrations of both free and complexed clofazimine were 0.1 microg/ml. Free and complexed clofazimine inhibited the growth of MAC inside macrophages to a similar extent, while modified cyclodextrin alone had no observable effects on MAC or macrophages. Complexed clofazimine was not toxic to cells at concentrations effective against MAC. The TD(50) of the modified cyclodextrin in THP-1 cell line was 297 microg/ml. (AU).
Descritores:ANTIINFECCIOSOS/quim
ANTIINFECCIOSOS/farmacol
ANTIINFECCIOSOS/tox
CLOFAZIMINA/quim
CLOFAZIMINA/farmacol
CLOFAZIMINA/tox
CELULAS CULTIVADAS
MACROFAGOS/ef drogas
MACROFAGOS/microbiol
TESTES DE SENSIBILIDADE MICROBIANA
COMPLEXO MYCOBACTERIUM AVIUM/ef drogas
ESTEROIS/quim
ACIDO SUCCINICO/quim
Limites:ESTUDO COMPARATIVO
HUMANO
ANIMAL
CAMUNDONGOS
Meio Eletrônico: - .
Localização:BR191.1; 09082/s


  4 / 4 HANSEN  
              first record previous record
seleciona
para imprimir
Id:14199
Autor:O'Connor, Robert; O'Sullivan, J. F; O'Kennedy, Richard
Título:The pharmacology, metabolism, and chemistry of clofazimine
..-
Fonte:s.l; s.n; 1995. 24 p. ilus, tab.
Descritores:HANSENIASE
MICOBACTERIOSE
ABSORÇAO
DISPONIBILIDADE BIOLOGICA
CROMATOGRAFIA LIQUIDA DE ALTA PRESSAO
CLOFAZIMINA
CLOFAZIMINA
CLOFAZIMINA
CLOFAZIMINA
SISTEMA IMUNE
RELAÇAO ESTRUTURA-ATIVIDADE
Localização:BR191.1; 06974/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information